Cisternostomy for malignant middle cerebral artery infarction: proposed pathophysiological mechanisms and preliminary

Salvatore Massimiliano Cardali1, Maria Caffo1, Gerardo Caruso2

  • 1Department of Biomedical and Dental Sciences and Morphofunctional Imaging, Neurosurgical Clinic, University of Messina, Messina, Italy.

Insights

Cisternostomy, a novel surgical approach for malignant middle cerebral artery ischemia, offers favorable outcomes. This treatment avoids cranioplasty, reducing potential complications and improving patient recovery.

Area of Science:

  • Neurosurgery
  • Neurology
  • Vascular Surgery

Background:

  • Middle cerebral artery (MCA) ischemic stroke presents high mortality and morbidity.
  • Current treatments for MCA stroke are not always effective.
  • Decompressive craniectomy can mitigate secondary brain damage from increased intracranial pressure.

Purpose of the Study:

  • To evaluate the efficacy of a novel surgical treatment for malignant MCA ischemia.
  • To assess the outcomes of cisternostomy in patients with MCA stroke.

Main Methods:

  • 16 patients with malignant MCA ischemia underwent cisternostomy between August 2018 and December 2019.
  • Diagnosis was confirmed via clinical history, neurological examination, and neuroimaging (CT, CT angiography, MRI).
  • Patient outcomes were assessed using the Glasgow Coma Scale and National Institutes of Health Stroke Scale.

Main Results:

  • The study included 16 patients (10 males, 6 females; mean age 60.1 years).
  • Two deaths (12.5%) were recorded.
  • A favorable functional outcome (mRS 0-3) was observed in 9 patients (64.2%) at 9 months post-discharge; 5 patients (35.7%) had a poor outcome (mRS 4-6).

Conclusions:

  • Cisternostomy demonstrated functional outcomes comparable to decompressive craniectomy.
  • This technique potentially eliminates the need for cranioplasty, avoiding associated complications.
  • Further studies with larger cohorts are required to confirm these findings.
Abstract

Related Concept Videos